All‐cause mortality · people with liver metastases
1 finding from 1 review
Time to mortality (overall survival) · people with liver metastases
It is very uncertain whether microwave coagulation changes time to mortality (overall survival) compared with conventional surgery (very low certainty).
1 finding from 1 review
All‐cause mortality · adults with hepatorenal syndrome
It is very uncertain whether transjugular intrahepatic portosystemic shunts changes all‐cause mortality compared with conventional treatment (very low certainty).
1 finding from 1 review
All‐cause morbidity · adults with hepatorenal syndrome
Transjugular intrahepatic portosystemic shunts showed no clear difference in morbidity due to any cause compared with conventional treatment (low certainty).
1 finding from 1 review
Serious adverse events · adults with hepatorenal syndrome
It is very uncertain whether transjugular intrahepatic portosystemic shunts changes serious adverse events compared with conventional treatment (very low certainty).
1 finding from 1 review
Health‐related quality of life · adults with hepatorenal syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participants who did not receive a liver transplant · adults with hepatorenal syndrome
It is very uncertain whether transjugular intrahepatic portosystemic shunts changes participants who did not receive a liver transplant compared with conventional treatment (very low certainty).
1 finding from 1 review
Participants without improvement in kidney function · adults with hepatorenal syndrome
Transjugular intrahepatic portosystemic shunts showed no clear difference in participants without improvement in kidney function compared with conventional treatment (low certainty).
1 finding from 1 review
Length of hospitalisation (days) · adults with hepatorenal syndrome
1 finding from 1 review
Intervention not reported
All‐cause mortality · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events at longest · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality short‐term · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes all‐cause mortality short‐term compared with moderate NMB (very low certainty).
1 finding from 1 review
Serious adverse events (SAEs) start of surgery until 8 hours after surgery · adults undergoing intra‐ and transperitoneal laparoscopic procedures
1 finding from 1 review
Health‐related quality of life · adults undergoing intra‐ and transperitoneal laparoscopic procedures
1 finding from 1 review
Serious adverse events (SAEs) start of surgery until 8 hours after surgery · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes serious adverse events (SAEs) start of surgery until 8 hours after… compared with moderate NMB (very low certainty).
1 finding from 1 review
Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes short‐term serious adverse events (SAEs) compared with moderate NMB (very low certainty).
1 finding from 1 review
All‐cause mortality ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures
It is very uncertain whether summary of findings table ‐ Deep neuromuscular blockade (NMB) changes short‐term serious adverse events (SAEs) compared with shallow NMB (very low certainty).
1 finding from 1 review